Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

373 Views

043. Clinical Trials: Thursday, 12:15 - 1:30 p.m.

Poster Session: Clinical Trials

(385) Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Grant C. Paulsen, MD (he/him/his)

Associate Professor
Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States
LS

Lawrence Sher, MD

Peninsula Research Associates
Rolling Hills Estates, California, United States
CS

Charu Sabharwal, MD, MPH

Dr
Pfizer Inc
Pearl River, New York, United States
NK

Nicholas Kitchin, MD

Sr Director, Vaccine Clinical Research & Development
Pfizer Inc
Hurley, Berkshire, England, United Kingdom
SH

Sungeen Hill, MD

Vaccine Research and Development, Pfizer Ltd
Hurley, England, United Kingdom

Presenting Author(s)

Emily Wasserman, MD (she/her/hers)

Associate Director
Vaccine Research and Development, Pfizer Inc
Pearl River, New York, United States

Co-Author(s)

XX

Xia Xu, PhD

Ms
Pfizer Inc
Collegeville, Pennsylvania, United States
Yvonne A. Maldonado, MD

Professor
Stanford University
Stanford, California, United States
EB

Elizabeth Barnett, MD

Professor of Pediatrics
Boston Medical Center
Boston, Massachusetts, United States
Janet A. Englund, MD

Professor
Seattle Children’s Hospital
Seattle, Washington, United States
EW

Emmanuel Walter, MD

Duke Human Vaccine Institute
Durham, North Carolina, United States
Flor M. Munoz, MD, MSc

Associate Professor of Pediatrics
Baylor College of Medicine
Houston, TX, United States
Eric Simoes, MD DCH

Professor of Pediatrics and Epidemiology
University of Colorado School of Medicine and Colorado School of Public Health
Denver, CO, United States
KT

Kawsar R. Talaat, MD (she/her/hers)

Associate Professor
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD, United States
Satoshi Kamidani, MD, PhD (he/him/his)

Assistant Professor of Pediatrics in Infectious Diseases
Emory University School of Medicine and Children's Healthcare of Atlanta
Suwanee, GA, United States
LM

Lisa Moyer, BS

Ms
Pfizer Inc
Collegeville, Pennsylvania, United States
VP

Vrunda Parikh, PharmD

Vaccine Research and Development, Pfizer Inc
Pearl River, Pennsylvania, United States
HM

Hua Ma, PhD

Vaccine Research and Development, Pfizer Inc
Collegeville, Pennsylvania, United States
XW

Xingbin Wang, PhD

Vaccine Research and Development, Pfizer Inc
Collegeville, Pennsylvania, United States
KK

Kenneth Koury, PhD

Head of Statistics and Modeling
Pfizer
Pearl River, NY, United States
AA

Annaliesa S. Anderson, PhD

SVP & CSO
Pfizer
New York, New York, United States
KS

Kena A. Swanson, Ph.D.

Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States
AG

Alejandra C. Gurtman, M.D.

Vice President
Pfizer
Pearl River, New York, United States
William C. Gruber, MD

SVP
Pfizer
Pearl River, New York, United States